← All trials

NCT05894343

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
May 19, 2023
Primary completion
May 31, 2028
Completion date
May 31, 2028
First posted
Jun 8, 2023
Last posted
Jun 8, 2023
Enrollment
14
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.